CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Systemic lupus erythematosus (SLE) is characterized by the pathological activation and differentiation of B lymphocytes. The B-lymphocyte stimulator (BLyS), also known as B cell-activating factor of the tumor necrosis factor family (BAFF), and its homologue, a proliferation-inducing ligand (APRIL),...

Full description

Bibliographic Details
Main Authors:	T. A. Panafidina, M. A. Sokhova, T. V. Popkova, M. V. Cherkasova, A. A. Novikov, E. N. Aleksandrova, E. L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2016-07-01
Series:	Научно-практическая ревматология
Subjects:	systemic lupus erythematous baff/blys april systemic lupus erythematosus sledai-2k lupus nephritis
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2203

Similar Items

CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
by: E. V. Suponitskya, et al.
Published: (2014-10-01)

Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers
by: David Aguirre-Valencia, et al.
Published: (2020-01-01)

CYTOKINE PROFILE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Maria Eduardovna Tsanyan, et al.
Published: (2013-12-01)

A Review of Anti-C Reactive Protein Antibodies in Systemic Lupus Erythematosus
by: Richter Patricia, et al.
Published: (2021-06-01)

Serum level of CXCL 12 in patients with systemic lupus erythematosus: Is it worthy for predilection of lupus nephritis?
by: Rehab A. Sallam, et al.
Published: (2021-01-01)

Irreversible organ damages in a cohort of patients with systemic lupus erythematosus (RENAISSANCE)
by: E. A. Aseeva, et al.
Published: (2016-10-01)

B cells targeting therapy in the management of systemic lupus erythematosus
by: Wen Shi Lee, et al.
Published: (2020-01-01)

Pesquisa de anticorpos antinucleossoma em lúpus eritematoso sistêmico Detection of antinucleosome antibodies in systemic lupus erythematosus
by: Isabella Lima, et al.
Published: (2007-06-01)

Biomarkers in biological fluids and their potential use as indicators of lupus nephritis in individuals with systemic lupus erythematous
by: Lisandro Pacheco-Lugo, et al.
Published: (2014-05-01)

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date
by: Lenert A, et al.
Published: (2017-03-01)

Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic
by: E. L. Nasonov, et al.
Published: (2021-05-01)

The 2019 updated EULAR/ERA-EDTA guidelines for the management of lupus nephritis. Expert comments. Part I
by: N. L. Kozlovskaya, et al.
Published: (2020-11-01)

Clinical and electrophysiological assessment of cranial and peripheral neuropathies in systemic lupus erythematosus patients: Relation to disease activity
by: Heba A. Almokadem, et al.
Published: (2021-10-01)

Decreased Daily Melatonin Levels in Women with Systemic Lupus Erythematosus - A Short Report
by: Ralitsa Robeva, et al.
Published: (2013-09-01)

AN OVERVIEW OF THE VI EULAR SCIENTIFIC EDUCATIONAL COURSE DEDICATED TO SYSTEMIC LUPUS ERYTHEMATOSUS (PISA, ITALY, SEPTEMBER 1–6, 2013)
by: T. A. Panafidina
Published: (2014-06-01)

Dosagem sérica de adenosina deaminase em lúpus eritematoso sistêmico: ausência de associação com atividade de doença Levels of serum adenosine deaminase in systemic lupus erythematosus: lack of association with disease activity
by: Isabella Lima, et al.
Published: (2005-10-01)

Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab
by: M É Tsanian, et al.
Published: (2013-05-01)

Transcriptomic studies of systemic lupus erythematosus
by: Masahiro Nakano, et al.
Published: (2021-04-01)

Anti‐dsDNA, anti‐nucleosome, anti‐C1q, and anti‐histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity
by: Xiaoying Shang, et al.
Published: (2021-06-01)

Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis
by: Justa Friebus-Kardash, et al.
Published: (2019-11-01)

Anti-dsDNA negative and anti-Ro positive lupus nephritis: a report of a rare case
by: D. Jain, et al.
Published: (2014-03-01)

EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. A. Aseeva, et al.
Published: (2015-09-01)

The role of Dickkopf-1 as a biomarker in systemic lupus erythematosus and active lupus nephritis
by: Mervat E. Abdelazeem, et al.
Published: (2021-03-01)

A multisystem syndrome compatible with systemic lupus erythematosus: Case report and review of literature
by: Samira Alesaeidi, et al.
Published: (2021-07-01)

Mycophenolate versus cyclophosphamide for lupus nephritis
by: M Sahay, et al.
Published: (2018-01-01)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
by: Gabriella Moroni, et al.
Published: (2010-01-01)

Towards Precision Medicine in Systemic Lupus Erythematosus
by: Lever E, et al.
Published: (2020-02-01)

Non-lupus glomerulonephritis in a patient with systemic lupus erythematosus
by: Emad Abdallah, et al.
Published: (2015-01-01)

SURVIVAL RATES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: REGIONAL REGISTRY DATA
by: R. R. Ismagilova, et al.
Published: (2020-04-01)

Characteristics of systemic lupus erythematosus and lupus nephritis in children in the Republic of Belarus and the Republic of Tatarstan
by: T. P. Makarova, et al.
Published: (2019-11-01)

Pregnancy in Systemic Lupus Erythematosus Patients with Nephritis
by: Panagiotis Pateinakis, et al.
Published: (2014-07-01)

Bullous systemic lupus erythematosus: An uncommon diagnosis in an 8-year-old girl
by: Uttam Lenka, et al.
Published: (2016-01-01)

B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus
by: Francesca Romana Spinelli, et al.
Published: (2019-11-01)

Programmed immunoadsorption with regeneration of adsoption columns in the treatment of lupus nephritis
by: A. A. Sokolov, et al.
Published: (2020-09-01)

Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus
by: Živković Valentina, et al.
Published: (2014-01-01)

Expression of BAFF and BR3 in patients with systemic lupus erythematosus
by: J.H. Duan, et al.
Published: (2016-03-01)

Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab
by: Francesca Regola, et al.
Published: (2019-04-01)

Azathioprine induced pancytopenia: A serious complication
by: Hadda V, et al.
Published: (2009-01-01)

Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01)

Current and Emerging Therapy on Lupus Nephritis
by: Lucky Aziza Bawazier
Published: (2018-01-01)